Kristian Reich
Founder at MOONLAKE IMMUNOTHERAPEUTICS
Net worth: 134 M $ as of 2024-04-29
Kristian Reich active positions
| Companies | Position | Start | End |
|---|---|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Chief Tech/Sci/R&D Officer | 2022-04-04 | - |
| Founder | 2022-04-04 | - | |
Moonlake Immunotherapeutics AG
 Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Chief Tech/Sci/R&D Officer | 2021-04-30 | - |
| Founder | 2021-04-30 | - | |
| JeruCON Beratungsgesellschaft mbH | Chief Tech/Sci/R&D Officer | - | - |
| Founder | - | - | |
derma2go AG
 derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Director/Board Member | - | - |
| Dermagnostix GmbH | Director/Board Member | - | - |
| Proderma Foundation | Director/Board Member | - | - |
Career history of Kristian Reich
Former positions of Kristian Reich
| Companies | Position | Start | End |
|---|---|---|---|
Dermatologikum Hamburg GmbH
 Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Corporate Officer/Principal | 2004-12-31 | 2014-12-31 |
| University of Gottingen | Corporate Officer/Principal | 1995-12-31 | - |
Training of Kristian Reich
| University of Freiburg | Undergraduate Degree |
| Technische Universität München | Doctorate Degree |
| University of Gottingen | Doctorate Degree |
Statistics
International
| Germany | 8 |
| Switzerland | 4 |
Operational
| Chief Tech/Sci/R&D Officer | 3 |
| Founder | 3 |
| Doctorate Degree | 3 |
Sectoral
| Consumer Services | 4 |
| Health Technology | 3 |
| Health Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| MOONLAKE IMMUNOTHERAPEUTICS | Health Technology |
| Private companies | 6 |
|---|---|
Dermatologikum Hamburg GmbH
Dermatologikum Hamburg GmbH Medical/Nursing ServicesHealth Services Dermatologikum Hamburg GmbH operates dermatologist clinics. Its services include prevention and skin checks, phototherapy, general dermatology, acne and rosacea, hair and scalp disorders, skin cancer and dermatological oncology, psoriasis, neurodermatitis and vascular & venous disease treatment. The company was founded by Volker Steinkraus in September 1997 and is headquartered in Hamburg, Germany. | Health Services |
derma2go AG
derma2go AG Internet Software/ServicesTechnology Services Derma2go AG operates an online platform for dermatological consultation. The company is based in Zurich, Switzerland. The Swiss company was founded in 2018 by Christian Greis and Vahid Djamei. Christian Greis has been the CEO since 2018. | Technology Services |
Moonlake Immunotherapeutics AG
Moonlake Immunotherapeutics AG Pharmaceuticals: MajorHealth Technology Part of MoonLake Immunotherapeutics, Moonlake Immunotherapeutics AG is a Swiss clinical-stage biopharmaceutical company. The company is based in Zug, Switzerland. The company was founded in 2021 by Jorge Santos da Silva, Arnout Ploos van Amstel, and Kristian Reich. Jorge Santos da Silva has been the CEO since 2021. Moonlake Immunotherapeutics was acquired by Helix Acquisition Corp. on April 05, 2022 for $395.41 million. | Health Technology |
| JeruCON Beratungsgesellschaft mbH | |
| Dermagnostix GmbH | |
| Proderma Foundation |
- Stock Market
- Insiders
- Kristian Reich
- Experience
